These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22870355)

  • 21. Prevalence of hyperprolactinemia in schizophrenia: association with typical and atypical antipsychotic treatment.
    Montgomery J; Winterbottom E; Jessani M; Kohegyi E; Fulmer J; Seamonds B; Josiassen RC
    J Clin Psychiatry; 2004 Nov; 65(11):1491-8. PubMed ID: 15554761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperprolactinemia: a 12-year retrospective study at gynecologic endocrinology unit, Siriraj Hospital.
    Saejong R; Dangrat C; Techatrisak K; Angsuwatthana S; Rattanachaiyanont M; Tanmahasamut P
    J Med Assoc Thai; 2013 Oct; 96(10):1247-56. PubMed ID: 24350404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperprolactinemia/Prolactinomas in the Postmenopausal Period: Challenges in Diagnosis and Management.
    Pekić S; Medic Stojanoska M; Popovic V
    Neuroendocrinology; 2019; 109(1):28-33. PubMed ID: 30347396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperprolactinemia during cocaine withdrawal.
    Mendelson J; Teoh S; Lange U; Mello N; Weiss R; Skupny A
    NIDA Res Monogr; 1988; 81():67-73. PubMed ID: 3136392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HYPERTHYROIDISM AND HYPERPROLACTINEMIA: IS THERE ANY ASSOCIATION?
    Sanjari M; Safi Z; Tahroodi KM
    Endocr Pract; 2016 Dec; 22(12):1377-1382. PubMed ID: 27540882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone loss associated with hyperprolactinemia in patients with schizophrenia.
    Kinon BJ; Liu-Seifert H; Stauffer VL; Jacob J
    Clin Schizophr Relat Psychoses; 2013 Oct; 7(3):115-23. PubMed ID: 23395836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of trichoscopy versus trichogram for diagnosis of female androgenetic alopecia.
    Galliker NA; Trüeb RM
    Int J Trichology; 2012 Jan; 4(1):19-22. PubMed ID: 22628985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Potentially Prolactin-Related Adverse Events and Sexual Maturation in Adolescents with Schizophrenia Treated with Paliperidone Extended-Release (ER) for 2 Years: A Post Hoc Analysis of an Open-Label Multicenter Study.
    Gopal S; Lane R; Nuamah I; Copenhaver M; Singh J; Hough D; Bach M; Savitz A
    CNS Drugs; 2017 Sep; 31(9):797-808. PubMed ID: 28660406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone.
    Kinon BJ; Gilmore JA; Liu H; Halbreich UM
    Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():55-68. PubMed ID: 12650681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human scalp hair follicles are both a target and a source of prolactin, which serves as an autocrine and/or paracrine promoter of apoptosis-driven hair follicle regression.
    Foitzik K; Krause K; Conrad F; Nakamura M; Funk W; Paus R
    Am J Pathol; 2006 Mar; 168(3):748-56. PubMed ID: 16507890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single- center experience of prolactin-producing pituitary adenomas without hyperprolactinemia: Its incidence and clinical management.
    Ogawa Y; Tominaga T
    Clin Neurol Neurosurg; 2020 Nov; 198():106123. PubMed ID: 32818756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Endocrine constellation in androgenetic alopecia in the female].
    Schmidt JB
    Wien Klin Wochenschr; 1987 Jan; 99(1):21-4. PubMed ID: 3105180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiandrogenic Therapy with Ciproterone Acetate in Female Patients Who Suffer from Both Androgenetic Alopecia and Acne Vulgaris.
    Coneac A; Muresan A; Orasan MS
    Clujul Med; 2014; 87(4):226-34. PubMed ID: 26528029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of nomifensine on growth hormone and prolactin secretion in normal subjects and in pathological hyperprolactinemia.
    Dallabonzana D; Spelta B; Botalla L; Oppizzi G; Silvestrini F; Chiodini PG; Liuzzi A
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1125-8. PubMed ID: 7076795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Macroprolactinemia associated with pituitary macroadenoma: treatment with quinagolide].
    Lakatos G; Szücs N; Kender Z; Czirják S; Rácz K
    Orv Hetil; 2010 Jun; 151(26):1072-5. PubMed ID: 20558354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical evaluation of the prolactin secreting capacity for the diagnosis of occult hyperprolactinemia].
    Matsuoka R; Mori H; Tomonari R; Chen SZ; Kigawa T; Aisaka K
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Apr; 39(4):586-90. PubMed ID: 3108420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hormones and hair growth].
    Trüeb RM
    Hautarzt; 2010 Jun; 61(6):487-95. PubMed ID: 20502852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Management of androgenetic alopecia in postmenopausal women].
    Rivera R; Guerra-Tapia A
    Actas Dermosifiliogr; 2008 May; 99(4):257-61. PubMed ID: 18394400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pituitary imaging is indicated for the evaluation of hyperprolactinemia.
    Bayrak A; Saadat P; Mor E; Chong L; Paulson RJ; Sokol RZ
    Fertil Steril; 2005 Jul; 84(1):181-5. PubMed ID: 16009175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperprolactinemia due to spontaneous intracranial hypotension.
    Schievink WI; Nuño M; Rozen TD; Maya MM; Mamelak AN; Carmichael J; Bonert VS
    J Neurosurg; 2015 May; 122(5):1020-5. PubMed ID: 25380110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.